Zensar Technologies acquires BridgeView Life Sciences in $14 million deal, aims for further acquisitions
Jul 17, 2024•over 1 year ago
Acquiring Company
Zensar Technologies
Acquired Company
BridgeView Life Sciences
Description
Zensar Technologies Ltd has announced its acquisition of BridgeView Life Sciences, an American IT and operations services firm, in an all-cash deal valued at $14 million. The acquisition is in line with Zensar's strategy to expand its portfolio and pursue growth opportunities, particularly strengthening its healthcare and life sciences division.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed